Literature DB >> 30480744

Bioinformatics Analysis of Weighted Genes in Diabetic Retinopathy.

Zhi-Peng You1, Yu-Lan Zhang1, Bing-Yang Li1, Xin-Gen Zhu2, Ke Shi1.   

Abstract

Purpose: Intricate signaling networks and transcriptional regulators translate pathogen recognition into defense responses. The aim of this study was to identify the weighted genes involved in diabetic retinopathy (DR) in different rodent models of diabetes.
Methods: We performed a gene coexpression analysis of publicly available microarray data, namely, the GSE19122 dataset from the Gene Expression Omnibus database. We conducted gene coexpression analysis on the microarray data to identify modules of functionally related coexpressed genes that are differentially expressed in different rodent models. We leveraged a richly curated expression dataset and used weighted gene coexpression network analysis to construct an undirected network. We screened 30 genes in the most closely related module. A protein-protein interaction network was constructed for the genes in the most related module using the Search Tool for the Retrieval of Interacting Genes. Gene Ontology enrichment analysis and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis were performed for the 30 genes.
Results: Five visual perception-related genes (Pde6g, Guca1a, Rho, Sag, and Prph2) were significantly upregulated. Based on the competing endogenous RNA hypothesis, a link between the long noncoding RNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) and visual perception-related mRNAs was constructed using bioinformatics tools. Six potential microRNAs (miR-155-5p, miR-1a-3p, miR-122-5p, miR-223-3p, miR-125b-5p, and miR-124-3p) were also screened. Conclusions: MALAT1 might play important roles in DR by regulating Sag and Guca1a through miR-124-3p and regulating Pde6g through miR-125b-5p.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30480744     DOI: 10.1167/iovs.18-25515

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  8 in total

1.  SERPINH1, Targeted by miR-29b, Modulated Proliferation and Migration of Human Retinal Endothelial Cells Under High Glucose Conditions.

Authors:  Lingfei Hu; Yinping Liu; Chaobing Wei; Huixiang Jin; Lixin Mei; Changfan Wu
Journal:  Diabetes Metab Syndr Obes       Date:  2021-08-04       Impact factor: 3.168

2.  Identification of TIMELESS and RORA as key clock molecules of non-small cell lung cancer and the comprehensive analysis.

Authors:  Haocheng Xian; Yuan Li; Boliang Zou; Yajuan Chen; Houqing Yin; Xuejun Li; Yan Pan
Journal:  BMC Cancer       Date:  2022-01-25       Impact factor: 4.430

3.  Identification and validation of hub genes for diabetic retinopathy.

Authors:  Li Peng; Wei Ma; Qing Xie; Baihua Chen
Journal:  PeerJ       Date:  2021-09-13       Impact factor: 2.984

4.  Homeodomain-containing gene 10 contributed to breast cancer malignant behaviors by activating Interleukin-6/Janus kinase 2/Signal transducer and activator of transcription 3 pathway.

Authors:  Jun Shen; Meng Wang; Fan Li; Huanhuan Yan; Jun Zhou
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

5.  MicroRNA-93-5p participates in type 2 diabetic retinopathy through targeting Sirt1.

Authors:  Hui Wang; Xian Su; Qian-Qian Zhang; Ying-Ying Zhang; Zhan-Ya Chu; Jin-Ling Zhang; Qian Ren
Journal:  Int Ophthalmol       Date:  2021-07-27       Impact factor: 2.031

6.  SP1-mediated lncRNA PVT1 modulates the proliferation and apoptosis of lens epithelial cells in diabetic cataract via miR-214-3p/MMP2 axis.

Authors:  Jun Yang; Shaozhen Zhao; Fang Tian
Journal:  J Cell Mol Med       Date:  2019-11-21       Impact factor: 5.310

7.  Gene polymorphism and plasma levels of miR-155 in diabetic retinopathy.

Authors:  E R Polina; F M Oliveira; R C Sbruzzi; D Crispim; L H Canani; K G Santos
Journal:  Endocr Connect       Date:  2019-12       Impact factor: 3.335

8.  TRIM59 Promotes Retinoblastoma Progression by Activating the p38-MAPK Signaling Pathway.

Authors:  Chao Wu; Xue-Qin Shang; Zhi-Peng You; Qi-Fang Jin; Yu-Lan Zhang; Yue Zhou; Yue-Zhi Zhang; Ke Shi
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-08-03       Impact factor: 4.799

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.